Cephalothin, cefazolin, cephradine, and cefoxitin inhibited more than 75% of 326 anaerobic bacteria in vitro, but cefoxitin was the most effective against anaerobes in general and Bacteroides fragilis in particular.
Sutter and Finegold (6) reported that only 11% of 124 strains of Bacteroides fragilis were inhibited by cephalothin at 32 ,g/ml, 13% by cefazolin at 12.5 ,ug/ml, and 38% by cephaloridine at 25 pkg/ml, whereas 86% were inhibited by cefoxitin at 16 ug/ml. Tally et al. (7) observed that 82% of the B. fragilis isolates were inhibited by cefoxitin, whereas cephalothin, cephaloridine, and cephalexin were less effective. They concluded that cefoxitin was the most effective among the cephalosporins tested against B. fragilis, an important anaerobic pathogen. Our report concerns the in vitro efficacy of cefoxitin compared with that of cephalothin, cefazolin, and cephradine.
(This work was presented in part at the 76th Annual Meeting of the American Society for Microbiology, May 1976.)
Three hundred and twenty-six recent clinical anaerobic isolates, two-thirds of which were from the female genital tract, were tested against cephalothin and cefazolin (Eli Lilly & Co., Indianapolis, Ind.), cephradine (Squibb and Co., Princeton, N.J.), and cefoxitin (Merck Sharp & Dohme, West Point, Pa.) at six different concentrations (2, 4, 8, 16, 32, and 64 ,ug) . The details of identification of the anaerobes and the description of inocula, media, and methods were as reported earlier (5) .
The minimal inhibitory concentrations were as shown in Tables 1 and 2 . Assuming a serum level of 32 ,ug/ml as the cutoff point, cefoxitin was the most effective of all four cephalosporins tested against anaerobes in general and B. fragilis in particular. Anaerobic cocci were generally susceptible to all four cephalosporins tested. Cephalothin at 32 ,g/ml was effective against 75% (55 strains) ofB. fragilis. Cefazolin inhibited less than 60% of these strains. Cephradine, although effective against 85% of all anaerobes like other cephalosporins, inhibited only 35% of B. fragilis subsp. fragilis strains.
Tally et al. (7) reported that cefoxitin at 16 ,ug/ml was effective against 82% of the B. fragilis strains tested, but cephalothin, cefazolin, cephaloridine, and cephalexin at 32 ,ug/ml inhibited only 6, 45, 52, and 24% of strains, respectively. Sutter and Finegold (6) observed that cefoxitin and cephalothin at 32 ,ug/ml inhibited 100 and 11% ofB. fragilis, respectively. Cefoxitin, in our study, was found to be effective against 89% of the B. fragilis subsp. fragilis strains at 32 ,ug/ml. At this level, cephalothin also inhibited 75% of B. fragilis subsp. fragilis. In contrast, Martin et al. (2) reported that only 9% of 195 strains of B. fragilis tested were susceptible to cephalothin. Nearly twothirds of our isolates were from the female genital tract, whereas most isolates examined by Sutter and Finegold (6) and Tally et al. (7) were not; this might be why our strains were highly susceptible to cephalothin. Cefazolin is highly effective against anaerobic cocci, but it is not as effective as cefoxitin against the Bacteroides group of organisms. Cephalothin, in a comparative clinical trial, failed to prevent the onset of anaerobic infections associated with abdominal trauma (8) . Anaerobic bacterial colonization and anaerobic septicemias predominated to a greater extent among those treated with cephalothin than among those treated with clindamycin. Hackman and Wilkins found that cephalothin was ineffective against an experimental mixed infection containing B. fragilis and Fusobacterium necrophorum (1). They attributed this to the beta-lactamase susceptibility of cephalothin. In contrast, cefoxitin, a beta-lactamaseresistant cephalosporin, did not inhibit this combination of organisms. Cefoxitin, a cephalosporinase-resistant cephalosporin, is by far the most potent of all cephalosporins tested against anaerobic bacteria in vitro.
Our study confirms the earlier reports (6, 7) that cefoxitin is the most effective of all cephalosporins thus far tested against B. fragilis.
This, in addition to its resistance to hydrolysis by beta-lactamases (4) and the spectrum of activity against aerobic and facultative bacteria (3), places cefoxitin in a unique place among the cephalosporins.
